Mizagliflozin ameliorates diabetes induced kidney injury by inhibitor inhibit inflammation and oxidative stress
These findings indicate that MIZ can ameliorate DN by inhibiting SGLT1, inflammation, and oxidative stress.
Authors
- Shuhan Shi
- Yueting Li (ORCID: https://orcid.org/0000-0001-7332-0214)
- Hui Gao (ORCID: https://orcid.org/0000-0002-3755-8417)
- Zhimin Lin (ORCID: https://orcid.org/0009-0002-6034-1942)
Institutions
- Fujian Medical University (CN)
- Second Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- World Journal of Diabetes
- Published
- 2024-11-29
- DOI
- https://doi.org/10.4239/wjd.v16.i1.92711
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.72